Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vericel CorpVericel Corporation Reports 20.1% Revenue Growth to $237.2 Million for Fiscal Year 2024
Verona Pharma plcVerona Pharma Reports Launch of Ohtuvayre and Financial Developments for 2024
uniQure N.V.uniQure Reports $239.6 Million Net Loss for Fiscal Year 2024, Revenue Increases to $27.1 Million
Compass Therapeutics, Inc.Compass Therapeutics Reports $49.4 Million Net Loss for 2024, Licensing Revenue of $850,000
Endeavor Group Holdings, Inc.Endeavor Group Holdings Reports 29.5% Revenue Increase to $7.11 Billion for Fiscal Year 2024
Imunon, Inc.Imunon Reports $18.6 Million Net Loss for Fiscal Year 2024, Faces Funding Challenges
Ivanhoe Electric Inc.Ivanhoe Electric Reports $128.6 Million Net Loss for Fiscal Year 2024
Xencor IncXencor Reports $232.6 Million Net Loss and $110.5 Million Revenue for Fiscal Year 2024
NCR VOYIX CorpNCR Voyix Reports $2.83 Billion Revenue for Fiscal Year 2024, 11% Decrease from 2023
AMEDISYS INCAmedisys Reports $2.35 Billion Revenue with Decline in Operating Income for Fiscal Year 2024
CUMULUS MEDIA INCCumulus Media Reports $827.1 Million Revenue, Faces Increased Operating Loss
HERON THERAPEUTICS, INC. /DE/Heron Therapeutics Reports $13.6M Net Loss, 13.6% Revenue Growth in 2024
Frontdoor, Inc.Frontdoor, Inc. Reports 4% Revenue Growth and Significant Acquisition Impact for 2024
Vital Farms, Inc.Vital Farms Reports 28% Revenue Growth to $606.3 Million in Fiscal Year 2024
Thryv Holdings, Inc.Thryv Holdings Reports $824.2M Revenue Decline, Plans Transition to SaaS Model
Tango Therapeutics, Inc.Tango Therapeutics Reports $130.3 Million Net Loss and $42.1 Million Revenue for Fiscal Year 2024
Hayward Holdings, Inc.Hayward Holdings Reports 6% Revenue Growth to $1.052 Billion for Fiscal Year 2024
PAPA JOHNS INTERNATIONAL INCPapa John’s Reports $2.06 Billion Revenue for Fiscal Year 2024, Operating Income Increases
NovoCure LtdNovoCure Reports 19% Revenue Growth to $605.2 Million Despite Net Loss
Bank of New York Mellon CorpBank of New York Mellon Reports $18.5 Billion Revenue and $4.2 Billion Net Income for Fiscal Year 2024
Life Time Group Holdings, Inc.Life Time Group Holdings Reports 18.2% Revenue Growth to $2.62 Billion in 2024
Trulieve Cannabis Corp.Trulieve Cannabis Corp. Reports $1.19 Billion Revenue with 5.1% Growth for Fiscal Year 2024
MURPHY OIL CORPMurphy Oil Corporation Reports $486.5 Million Net Income for Fiscal Year 2024
Aurinia Pharmaceuticals Inc.Aurinia Pharmaceuticals Reports 36% Increase in Net Product Sales for Fiscal Year 2024
DUCOMMUN INC /DE/Ducommun Reports $786.6 Million Revenue and $31.5 Million Net Income for Fiscal Year 2024